MC
ELV icon

Menta Capital’s Elevance Health ELV Stock Holding History

Menta Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,360
Closed -$256K – 779
2017
Q2 		$256K Buy
+1,360
New +$244K 0.03% 675
2017
Q1 		– Sell
-3,086
Closed -$444K – 850
2016
Q4 		$444K Buy
+3,086
New +$413K 0.04% 649
2016
Q3 		– Sell
-10,760
Closed -$1.41M – 857
2016
Q2 		$1.41M Sell
10,760
-300
-3% -$41K 0.19% 138
2016
Q1 		$1.54M Buy
11,060
+3,480
+46% +$465K 0.21% 103
2015
Q4 		$1.06M Buy
+7,580
New +$1.04M 0.13% 241
2014
Q1 		– Sell
-20,300
Closed -$1.88M – 403
2013
Q4 		$1.88M Buy
+20,300
New +$1.8M 0.77% 23
2013
Q3 		– Sell
-2,600
Closed -$213K – 385
2013
Q2 		$213K Buy
+2,600
New +$195K 0.14% 309

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Menta Capital's ELV Position: Q3 2017 in Review

Menta Capital sold out of Elevance Health (ELV) in Q3 2017, closing a stake of 1,360 shares — an estimated $256K sold.

Menta Capital first reported a position in ELV in Q2 2013 and held it in 7 quarters. The position peaked at $1.88M in Q4 2013. 845 funds tracked by Wall St. Rank hold ELV as of Q3 2017.

  • Menta Capital reported no remaining Elevance Health position as of Q3 2017 after selling out during the quarter.
  • Menta Capital sold 1,360 Elevance Health shares in Q3 2017, an estimated $256K.
  • Menta Capital first reported a position in Elevance Health in Q2 2013 and held it in 7 quarters.
  • Menta Capital's Elevance Health position peaked at $1.88M in Q4 2013.
  • 845 funds tracked by Wall St. Rank held Elevance Health as of Q3 2017.

Based on Menta Capital's 13F filing for Q3 2017, filed 14 Nov 2017.